Kappa opioid receptors in excitatory spinal neurons gate acute pain: evidence from mouse and human
Preprint
Abstract
Summary: The kappa opioid receptor (KOR) has emerged as a promising, nonaddictive analgesic target, yet the neural mechanisms underlying KOR inhibition of pain are not entirely understood. Here, we provide converging evidence that KOR expressed on spinal neurons inhibits acute pain. We demonstrate that pharmacological inhibition of KOR-expressing neurons in the spinal cord blocks nocifensive behaviors. Conversely, chemogenetic activation of KOR-expressing spinal neurons elicits nocifensive behaviors. We then perform a series of molecular characterizations and show that excitatory KOR spinal neurons are recruited by noxious stimuli and coexpress pain-promoting neuropeptides such as Tac1 in both mouse and human. Together, these data suggest that kappa opioids inhibit pain by reducing the release of pain-promoting neuropeptides from a translationally relevant population of spinal neurons. In Brief: Kooij et al. find KOR signaling within the spinal cord suppresses pain transmission. Molecular characterization of KOR-expressing spinal neurons reveals this may occur through the inhibition of excitatory spinal neurons, which also express pain-promoting neuropeptides. Highlights: Spinal KOR signaling suppresses behavioral responses in rodent acute pain models Chemogenetic activation of Oprk1 Cre spinal neurons elicits nocifensive behaviors KOR is expressed on excitatory superficial dorsal horn neurons that contain the pain-promoting neuropeptide Tac1 (Substance P) in mouse KOR-expressing spinal neurons similarly reside in the superficial dorsal horn and coexpress TAC1 in human GraphicalKeywords
This publication has 83 references indexed in Scilit:
- Molecular Genetics of Kappa Opioids in Pain and Itch Sensations2020
- Recent advances in our understanding of the organization of dorsal horn neuron populations and their contribution to cutaneous mechanical allodyniaJournal of Neural Transmission, 2020
- Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain2019
- Molecular Architecture of the Mouse Nervous SystemCell, 2018
- Generation of a KOR‐Cre knockin mouse strain to study cells involved in kappa opioid signalingGenesis, 2015
- Effect of repeated administration of TRK-820, a κ-opioid receptor agonist, on tolerance to its antinociceptive and sedative actionsBrain Research, 2004
- Kappa-opioid receptor modulation of the release of substance P in the dorsal hornBrain Research, 1996
- KAPPA-/MU-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cordNeuroscience, 1992
- Sensory neuropeptide interactions in the production of plasma extravasation in the ratNeuroscience, 1992
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988